secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001654954-24-005695
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision Q1 2024 revenue $82K, net loss $2.7M; cash drops to $0.5M
----------------------------------------------------------------------------

- Q1 2024 revenue of $82,000; net loss of $2.7 million.
- Cash decreased from $1.5M (Mar 31) to $0.5M (May 6, 2024).
- LockeT submitted for CE Mark approval, expected Q3 2024; initial clinical data positive.
- Appointed Marie-Claude Jaques as Chief Commercial Officer effective May 1, 2024.
- Company is seeking additional financing to pursue business objectives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424005695/0001654954-24-005695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424005695/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-005695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer